NCT01383447 2017-08-08
Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Phase 1/2 Terminated
National Cancer Institute (NCI)
Medical University of South Carolina
City of Hope Medical Center
City of Hope Medical Center
Rutgers, The State University of New Jersey